SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-011853
Filing Date
2022-01-19
Accepted
2022-01-19 06:06:03
Documents
18
Period of Report
2022-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d146336d8k.htm   iXBRL 8-K 44424
2 EX-2.1 d146336dex21.htm EX-2.1 649322
3 EX-99.1 d146336dex991.htm EX-99.1 46064
7 GRAPHIC g146336g0119124204926.jpg GRAPHIC 2823
8 GRAPHIC g146336g0119124205145.jpg GRAPHIC 2681
9 GRAPHIC g146336g0119124205645.jpg GRAPHIC 2229
10 GRAPHIC g146336g0119124205895.jpg GRAPHIC 2493
  Complete submission text file 0001193125-22-011853.txt   1061225

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20220118.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20220118_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20220118_pre.xml EX-101.PRE 11262
12 EXTRACTED XBRL INSTANCE DOCUMENT d146336d8k_htm.xml XML 3343
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 22536730
SIC: 2834 Pharmaceutical Preparations